LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Miguel Escobar, MD
Memorial Hermann Texas Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dr. Jose Eleuterio Gonzalez Monterrey University Hospital
Monterrey, Nuevo León, Mexico
- Hematology Research Center of the Russian Academy of Medical Sciences
Moscow, Russia
- Charlotte Maxeke Johannesburg Academic Hospital, Hemophilia Comprehensive Care
Parktown, Gauteng, South Africa
- Worthwhile Clinical Trials, Lakeview Hospital
Benoni, South Africa
- University and Polytechnic Hospital la Fe, Hemostasis and Thrombosis Unit
Valencia, Spain
- City Scientific-Practical Center for Diagnosics
Kiev, Ukraine
- National Specialized Children'S Hospital Okhmatdyt, Centre for Hemostatic Pathology
Kyiv, Ukraine
- Institute of Blood Pathology and Transfusion Medicine
Lviv, Ukraine
- Ut Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Aug 2016
- Primary completion
- 6 Aug 2017
- Completion
- 31 Aug 2017
- Last update posted
- 25 Feb 2022
- Registered enrollment
- 12
- Registry id
- NCT02548143
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.